New Video Now Available: Discover the Key Insights in This MPN Session
- 2 days ago
- 2 min read

A new video is now available on the Global MPN Scientific Foundation YouTube channel, bringing valuable insights for patients, caregivers, researchers, and healthcare professionals interested in myeloproliferative neoplasms (MPNs).
In this session, important perspectives are shared on MPN in USA, Talking with Dr. Shatzel from OSHU, Oregon Health & Science University in Portland, and with the participation of patients, helping the community better understand current developments and discussions in the field of MPN.
At the Global MPN Scientific Foundation, our mission is to make reliable information accessible and to encourage collaboration between patients, physicians, and researchers worldwide.
If you want to hear directly from experts and explore the key ideas discussed in this conversation, the full video is now available to watch.
📺 Watch the full video here: https://youtu.be/q62Est8kzs8
We invite you to watch the session and share it with others who may find this information valuable.
If you would like to continue learning and connecting with others living with MPN, we invite you to explore the initiatives of the Global MPN Scientific Foundation.
📰 Subscribe to our newsletter to receive updates about research, webinars and community.
📝 Register for MPN JournalTrack your symptoms and treatment experience while contributing anonymously to a better understanding of life with MPN.
🌿 Explore the MPN Wellbeing ProjectA program designed to support quality of life through complementary practices that may help address symptoms and treatment side effects.
💬 Join our international WhatsApp patient groupsConnect with people living with MPN around the world and share experiences in a supportive community.
❤️ Support the Global MPN Scientific Foundation. Donations help expand education programs, international collaborations, and patient resources worldwide.
Together we continue building a stronger global network for people living with myeloproliferative neoplasms.


Comments